share_log

HC Wainwright & Co. Maintains Buy on Actinium Pharma, Maintains $50 Price Target

HC Wainwright & Co. Maintains Buy on Actinium Pharma, Maintains $50 Price Target

HC Wainwright & Co.维持对Actinium Pharma的买入,维持50美元的目标股价
Benzinga ·  03/19 11:19

HC Wainwright & Co. analyst Joseph Pantginis maintains Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price target.

HC Wainwright & Co. 分析师约瑟夫·潘吉尼斯维持Actinium Pharma(AMEX: ATNM)的买入并维持50美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发